ACIP Ends Universal Hepatitis B Vaccine at Birth

A U.S. panel of vaccine advisors, now led by a vaccine skeptic, has voted to end the long-standing recommendation for hepatitis B vaccinations at birth. This shift, which replaces a policy that prevented an estimated 90,000 deaths, allows for individual-based decision-making. Babies born to negative-testing mothers can now choose whether to receive the birth dose, while those born to positive-testing mothers should still receive it. The new guidance also suggests delaying the first shot until two months of age, though this recommendation faced opposition. The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.